Pharma Industry

India to roll out new drug policy, devise rules for clinical trials, say officials

Indian government is working with stakeholders to devise new rules for clinical trials that are expected to bring new projects to India.

IT Vendors Must Bolster Pharma Credentials In The APAC Market

According to Ovum, the global pharma industry is facing a number of key resistors to growth - in particular, the impending 2011 patent cliff.

Company's Growth Path Determines The Role Of IT

Delhi HC sets aside Centre's ban on 344 fixed dose combination medicines

Defending its stand, the Centre had argued that the FDC medicines are "new drugs" and thus, require licence from Drugs Controller General for sale and manufacture.

Hillary win may pose pricing challenges for pharma cos: Report

A Democrat sweep in US polls may pose even greater pricing challenges for the pharma industry and pave the way for tighter pricing regulations for both brand name and generic drugs, according to a report.

India needs predictable IPR regime, says Novartis

If the whole data regulatory process becomes predictable in the long run, it makes investment in the country more sustainable, said Novartis Pharma AG, Global Head of Development, Established Medicines Franchise, Lutz Hegemann.

US-India Business Council plan to up trade to $500 billion per year

Comprehensive plan includes resolving outstanding issues related to the civil nuclear deal, to increase FDI in the defence sector, e-commerce and insurance

IT Integration A Major Issue For Globetrotting Pharmas

With Indian pharma companies spreading their wings across the globe, IT will assume a much stronger role.

Indian Pharma Industry Gets IT Savvy

The pharma industry is keen on leveraging IT to achieve operational effieciency.